Papers and books published in English about cardiovascular issues

Ravnskov U. Aneurysm of the heart and the post-myocardial-infarction syndrome. Acta Med Scand 1968;183:393-5.  
Ravnskov U. Fluctuating pericardial effusion. N Engl J Med 1969;281:854.  
Ravnskov, U. Lowering cholesterol concentrations and mortality. BMJ 1990;301: 814.
Ravnskov U. An elevated serum cholesterol is secondary, not causal, in coronary heart disease. Medical Hypotheses 1991;36:238-41.
Ravnskov U. Atherogenicity and thrombogenicity indices. Lancet 338, 1328, 1991.
Ravnskov U. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ1992;305: 15-19. Letters: BMJ 1992;305:420-422, and 717.
Ravnskov U. The fragile links of the diet-heart chain. Nutrition Quarterly 1992;16:19-21.
Ravnskov U. Cardiovascular disease in developing countries. BMJ 1993;306:145-6.
Ravnskov U. Dietary fats and blood lipids as cardiovascular risk factors in the general population. A critical overview. Proceedings of the I. World Congress of Dairy Products in Human Health and Nutrition. Madrid 1993. Rotterdam: Balkema 1994, p 361-369.
Ravnskov U. Reducing serum cholesterol. Lower cholesterol of doubtful benefit to anyone. BMJ 1993;307:125.
Ravnskov U. Coronary atherosclerosis on angiography-progress or regress and why? Circulation 1993;88:1358-9.
Ravnskov U. Hypercholesterolemia does not cause coronary heart disease – evidence from the nephrotic syndrome. Nephron 1994;66:356-7.
Ravnskov U. Ischaemic heart disease and cholesterol. Optimism about drug treatment is unjustified. BMJ 1994;308:1038.
Ravnskov U. Is there a cause-effect relationship between high blood cholesterol and atherosclerosis? Workshop on cholesterol-lowering trials. National Heart, Lung and Blood Institute, Bethesda 1994.
Ravnskov U. What do angiographic changes after cholesterol lowering mean? Lancet 1994;344:1297.
Ravnskov U. Is intake of trans-fatty acids and saturated fat causal in coronary heart disease? Circulation 1994;90:2568-9.
Ravnskov U. Doing the right thing: stop worrying about cholesterol. Circulation 1994;90:2572-3.
Ravnskov U. Quotation bias in reviews of the diet-heart idea. J Clin Epidemiol 1995;48:713-719.
Ravnskov U. Implications of 4S evidence on baseline lipid levels. Lancet 1995;346:181.
Ravnskov U. Beneficial effects of simvastatin may be due to non-lipid actions. BMJ 1995;311:1436-1437.
Ravnskov U. The American College of Physicians guidelines on cholesterol screening. Ann Intern Med 1996; 125:1010-1011.
Ravnskov U. The questionable role of saturated and polyunsaturated fatty acids in cardiovascular disease. J Clin Epidemiol 1998;51:443-460.   Read also a dissent to the paper: Golomb BA. Dietary fats and heart disease-dogma challenged? and my answer; same journal and same issue. This paper won the Skrabanek award 1999
Ravnskov U. Why heart disease mortality is low in France. Author´s hypothesis is wrong. BMJ 1999;319:255
Ravnskov U. VAT and fat. Evidence is contradictory. BMJ 2000;320:1470
Ravnskov U. Prevention of atherosclerosis in children. Lancet 2000;355:69.
Ravnskov U. The Cholesterol Myths. Washington: New Trends Publishing, 2000; ISBN 0-9670897-0-0
Ravnskov U. Cholesterol and all-cause mortality in Honolulu. Lancet 2001; 358: 1907.
Ravnskov U. Diet-heart disease hypothesis is wishful thinking. BMJ 2002; 324: 238
Ravnskov U, Allan C, Atrens D, Enig MG, Groves B, Kaufman J, Kroneld R, Rosch PJ, Rosenman R, Werkö L, Nielsen JV, Wilske J, Worm N. Studies of dietary fat and heart disease. Science 2002; 295: 1464-5.
Ravnskov U. Statins as the new Aspirin. Conclusions from the heart protection study were premature. BMJ 2002;324:789.
Ravnskov U. Is atherosclerosis caused by high cholesterol? QJM 2002; 95: 397-403. This paper was also selected for publication in the third issue of South African Excerpts Edition of the QJM 2002
Ravnskov U. A hypothesis out-of-date: The diet-heart idea. J Clin Epidemiol,  2002 Nov;55(11):1057-63. Same issue: Dissent by W.S.Weintraub, and Reply by U. Ravnskov An evaluation of our discussion is available 
Ravnskov U. ASCOTT-LLA: Questions about the benefits of atorvastatin. Lancet 2003;361:1986.
Ravnskov U. Lipoproteins and cardiovascular risk. Lancet 2003;361:1988-1989.
Ravnskov U. The retreat of the diet-heart hypothesis. J Amer Phys Surg.  2003;8:no 3, 94-95
Ravnskov U. High cholesterol may protect against infections and atherosclerosis. QJM 2003;96:927-34. This paper has since long been one of the most-frequently read paper in QJM
Ravnskov U. Dietary fat intake and risk of stroke. Allegations about dietary fat are unfounded. BMJ 2003; 327:1348 
Ravnskov U. Inflammation, Cholesterol Levels, and Risk of Mortality Among Patients Receiving Dialysis. JAMA 2004;291:1833-1834.
Ravnskov U, Sutter MC.  Aggressive lipid-lowering therapy and regression of coronary atheroma. JAMA. 2004;292:38 
Ravnskov U, Rosch P, Sutter MC. Intensive lipid-lowering with atorvastatin in coronary disease. N Engl J Med 2005;353:94.
Ravnskov U. Dietary fat is not the villain. BMJ 2005;331:906-7. 
Ravnskov U, Rosch PJ, Sutter MC, Houston MC. Should we lower cholesterol as much as possible? BMJ 2006;332:1330-1332.
Ravnskov U, Rosch PJ, Sutter MC. High-Dose Statins and the IDEAL Study. JAMA 2006;295:2476. In their response the authors did not give us the requested information. 
Ravnskov U. Saturated fat does not affect blood cholesterol Am J Clin Nutr 2006;84:1550-51. Read also Martijn B Katan´s response as well as a discussion about our correspondence by Michael R Eades and others.
Ravnskov U. Lack of Evidence for Recommended Low-Density Lipoprotein Cholesterol Treatment Targets. Ann Intern Med 2007;146:614.
Ravnskov U. Cholesterol lowering and mortality: A sea of contradictions.Nutr Metab Cardiovasc Dis. 2007;17:e25-7
Accurso A et al. Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr Metabol 2008, 5:9
Ravnskov U. Re: The Association Between Statins and Cancer Incidence in a Veterans Population.J Ntl Cancer Inst 2008; doi: 10.1093/jnci/djn160
Ravnskov U. Should medical science ignore the past? BMJ 2008;337:a1681
Ravnskov U. The fallacies of the lipid hypothesis. Scand Cardiovasc J  2008;42-236-239
Ravnskov U, McCully KM. Vulnerable plaque formation from obstruction of vasa vasorum by homocysteinylated and oxidized lipoprotein aggregates complexed with microbial remnants and LDL autoantibodies. Ann Clin Lab Sci 2009;39:3-16
Ravnskov U. Fat and Cholesterol are GOOD for You. GB Publishing 2009.